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Research Paper: 
The Effects of Prenatal Norharman Exposure on 
Seizure Severity in Rats
Background: Norhraman is an alkaloid that can damage the nervous system.
Objective: This experimental study aimed to investigate the effects of prenatal norharman 
exposure on seizure severity in adult rats.
Methods: A total of 36 Wistar rats were randomly divided into 3 groups as follows: Control, 
sham (solvent), and norharman (1000 ug/kg). The sham and norharman groups were treated 
once daily for 8-18 of the fetal period. 2 months after birth, kindling was performed by the 
daily injection of Pentylenetetrazol (PTZ) (30 mg/kg); then, the seizure behavior was recorded 
for approximately 30 minutes. The obtained data were analyzed using Analysis of Variance 
(ANOVA) and Tukey’s posthoc test.
Results: The present study data indicated that administrating norharman in the fetal period 
increased seizure responses to PTZ, i.e., significant in the examined female rats (P<0.05).
Conclusion: According to the current research findings, the severity of seizures increases in 
subjects who have been exposed to norharman during the prenatal period.
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1. Introduction
eizures are defined as a sudden change 
in the function of the Central Nervous 
System (CNS) caused by the excessive 
depletion of neurons [1]. Seizures, at dif-
ferent ages, can have numerous causes, 
such as metabolic, structural, and pharmacological im-
pairments, CNS infections, including meningitis and 
encephalitis, vascular trauma, and hemorrhagic strokes 
[2-4]. Seizures occur following a disturbance in the bal-
ance between the excitatory and inhibitory systems of 
the brain. This imbalance can be genetic or acquired [5]. 
In patients with epilepsy, the prevalence of cardiovas-
cular, respiratory, and inflammatory diseases, diabetes, 
obesity, migraine, and arthritis has been reported to be 
further, compared to the general population. Moreover, 
these patients are at higher risks for bone fractures as 
well as sudden unexplained death [6]. Several models 
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are used to induce acute and chronic chemical, electrical, 
and pneumatic seizures [6, 7]. 
Pentylenetetrazole (PTZ) is a GABA-A receptor an-
tagonist. The Intraperitoneal (IP) injection of PTZ into 
an animal induces an acute and severe seizure at a high 
dose, while consecutive injections of a sub-convulsive 
dose have been used for generating chemical kindling, 
as an epilepsy model. Repetitive low-dose (30 mg/kg) 
injections of PTZ decrease the threshold to induce a con-
vulsive seizure [7]. Norharman, as an alkaloid, is present 
in the seeds and roots of pecan. There are 5 alkaloid de-
rivatives with indole structure in this plant, which include 
norharman, harman, harmin, harmaline, and harmalol, as 
the most well-known derivatives of beta-carbolines [8]. 
Norharman and harman are found in cigarettes, brewed 
coffee, meat extracts, and heat-cooked protein foods, as 
well as alcoholic beverages [9]. Additionally, beta-car-
bolines tend to attach GABA-A receptors and produce 
the opposite agonist effects; accordingly, they can cause 
seizures in high and anxious subjects in moderate doses 
[10-14]. The GABAergic system is the major inhibitory 
system of the brain; its suppression harms the balance 
of neuronal discharge. Thus, it increases the excitability 
of the brain and facilitates an increased susceptibility to 
seizures and the intensification of seizures [13]. Further-
more, norharman, as an active endogenous substance, 
can play a modulating role in cognitive function, espe-
cially in female rats [15]. 
Numerous studies have reported the bio-pharmaco-
logical effects of beta-carbolines on the eukaryotic and 
prokaryotic cells; subsequently, such impacts lead to 
changes in DNA replication and enzymatic activities 
involved in DNA sequencing [10]. Likewise, injecting 
beta-carbolines into the substantia nigra may cause neu-
ronal damage by inhibiting TPI triphosphate isomerase 
[16]. Some reports have indicated its adverse effects on 
this maternal during organogenesis, which resulted in dif-
ferent constant defects [17]. 
The main growth and development of the CNS occur 
during the embryonic period, based on the aforementioned 
points; the exposure of the embryo to beta-carbolines may 
affect its susceptibility to seizures. Using norharman-con-
taining substances is significantly on the rise. Thus, this 
study aimed to evaluate the effects of norharman admin-
istration on the severity of pentylenetetrazole-induced 
seizures in pregnant rats’ offspring in adulthood.
2. Materials and Methods
In total, 30 pregnant female Wistar rats (200-230 g) 
were obtained from Pasteur Institute (Karaj City, Iran). 
The examined animals were housed in standard polycar-
bonate cages in the animal room under12:12 h light/dark 
cycle at 22-20°C, a humidity of 55%-45%, and access to 
food and water ad libitum. 
This randomized experimental trial was conducted at 
Qazvin University of Medical Sciences, in Qazvin City, 
Iran, in 2020. Initially, the study rats were divided into 
3 groups, as follows: control (normal pregnancy), sham 
(0.2 mL ethanol as solvent), and norharman (1000 μg/
kg). The sham and norharman groups were given solvent 
or norharman (Sigma-USA) by gavage once a day for 10 
days from the eighth to 18th day of pregnancy. The 36 
offspring were randomly weaned 30 days after birth and 
separated by gender. 
The kindling was performed 2 months after birth by 
daily IP injection of PTZ at a dose of 30 mg/kg. Imme-
diately after PTZ injection, the study animals’ behaviors 
were precisely monitored for 30 min. The tests were per-
formed under standard conditions from 9 AM to 12 PM. 
To observe the examined animals’ behaviors, a trans-
parent polygalas container (30×30×30 cm) was used. 
Following PTZ injection, each animal presented a set of 
spontaneous behaviors whose severity was graded in 5 
scores, as follows: 0: no response, 1: ear and face jumps, 
–2: body myoclonic jumps, 3: myoclonic jumps, a sitting 
position with bilateral clonus of the forearms, 4: tonic-
colonic seizures, and 5: general tonic-colonic seizures 
and falling (the loss of the position). In experiments, the 
highest response was considered in each animal, and 
in the event of stage 4, the explore rat was considered 
kindled. Additionally, each study group that reached 
stage 4 earlier was considered more sensitive to the sei-
zure effect of PTZ [18]. The data were analyzed in SPSS 
using one-way Analysis of Varanine (ANOVA). Differ-
ences between the research groups were determined by 
Tukey’s test at P<0.05.
3. Results
Comparing the effects of norharman on PTZ-induced 
seizure in the male rats suggested the following findings:
Seizure severity and scores after injecting PTZ, in the 
norharman group were significantly higher than those 
in the control and solvent groups (P<0.05). Besides, in 
the norharman group, the time for all rats to reach stage 
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4 seizures was shorter than that in the controls. Corre-
spondingly, the largest difference in the severity of sei-
zures between the norharman group and the other study 
groups was detected during the 11th to 15th days after 
PTZ injection (Figures 1 and 2). 
Comparing the effects of norharman on PTZ-induced 
seizures in the female rats, the results signified that the 
prenatal administration of norharman resulted in a high-
er significant score of PTZ-induced seizures, compared 
to the control and solvent groups (P<0.05) (Figure 3). 
Norharman also significantly reduced the incidence time 
of severe seizures, compared with the control and sham 
groups. The mean seizure scores after PTZ injection dur-
ing the sixth, and eighth to thirteenth days in the norhar-
man group were higher than those in the other research 
groups. There was no significant difference between the 
control and sham groups in this respect (Figure 4).
4. Discussion
This study evaluated the effects of fetal norharman 
exposure on the seizure sensitivity of offspring by the 
pentylenetetrazole model in male and female rats. The 
collected results suggested that receiving norharman in 
the embryonic period increases the response to PTZ, es-
pecially in female rats. According to these findings, in-
dividuals who have been exposed to norharman during 
pregnancy are probably more prone to experience sei-
zures, compared to the general population. Studies ex-
plored the effect of abusing some drugs and compounds 
during the fetal period on the structure and behavior of 
living organisms; however, the effects of norharman em-
bryonic reception on the seizure sensitivity of offspring 
remains unstudied. Most similar studies have empha-
sized the negative impact of using these compounds in 
the physiological processes of the CNS or other organs 
of the body. For example, drug use, especially morphine, 
during pregnancy has been reported to impair spatial 
learning in rats; this occurs by altering opioid receptors, 
as well as differences in response to pain stimuli, com-
pared with healthy rats [19, 20]. In this regard, it has been 
claimed that even changes in the normal concentration of 
some maternal hormones during pregnancy cause alter-
nations in the structure of the hippocampus; thus, this 
 
Figure -1. Comparison of the Mean ± SEM score of PTZ-induced seizures in male rats: 
Consumption of norharman significantly intensifies PTZ-induced seizures in male animals. 





  Figure -3. Comparison of the Mean ± SEM score of PTZ -induced seizures in female rats:  
The score of PTZ -induced seizures in female animals of the norharman group was higher 

































Figure 1. Comparing the Mean±SEM scores of PTZ-induced seizures in male rats 
Consuming norharman significantly intensified PTZ-induced seizures in male animals (n=8), *P<0.05, compared with the control and 
solvent groups.
 
Figure -2. Comparison of the mean score of seizures induced by PTZ in the male rats: 
Consumption of norharman shortens stage 4 of seizures compere to control . 
 
Figure 2. Comparing the mean scores of seizures induced by PTZ in the male rats 
The consumption of norharman sh rtened stage 4 of seizures, compar d t  the controls.
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process reduces the mental capacity of newborn mice 
[21]. Besides, prenatal stress is dangerous and can play 
a role in causing congenital neurological diseases. For 
example, stress during pregnancy changes the activity 
of the hypothalamic-pituitary-adrenal axis of the fetus; 
this mechanism changes the structure and function of the 
brain in response to some stimulus of the CNS [18, 22]. 
Norharman is a beta-carboline alkaloid that can activate 
serotonin receptors. It also inhibits the enzyme mono-
amine oxidase and hydrogen and sodium exchanger [12, 
13]. The fetal period is a critical life stage in which the 
CNS is evolving and growing. In this context, a defect 
in the evolution of the GABAergic system has been 
detected in mice that received benzodiazepines during 
pregnancy. The GABAergic system plays an essential 
role in reducing the brain’s sensitivity to the activity of 
excitatory systems [18, 19]. 
Norharman is a benzodiazepine receptor reverse 
agonist; when used in the prenatal period, it may pres-
ent detrimental effects on the inhibitory systems of the 
brain [14]. In adult mice, binding to the GABA recep-
tor reduces the capacity of chlorine channels to open in 
response to the GABA anticonvulsant substance [23]. 
Beta-Carbolines have been described as co-enzyme. 
This is because they cause other mutant compounds. 
Receiving norharman in the embryonic period can lead 
to changes in DNA replication as well as the enzymatic 
activity involved in the process of modifying DNA se-
quences in eukaryotic and prokaryotic cells. Norharman 
also directly or indirectly prevents DNA repair; thus, it 
enhances mutations induced by ultraviolet or mutagenic 
chemicals [10]. 
Norharman has been reported to indirectly increase 





  Figure -3. Comparison of the Mean ± SEM score of PTZ -induced seizures in female rats:  
The score of PTZ -induced seizures in female animals of the norharman group was higher 

















Figure 3. Comparin  th  Mean±SEM scores of PTZ-induced seizure  in female rats 
The score of PTZ-induced seizures in female animals of the norharman group was higher than those in the control and sham groups; 
n=8. *P<0.05, compared with the control group.
Figure 4. Comparing the mean score of seizures induced by PTZ in female rats
Consuming norharman significantly caused the earlier onset of stage 4 seizures in the examined female rats.
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stress, cell apoptosis, or necrosis. The increment level of 
free radicals and neuroinflammation affect the incidence 
of epilepsy [24]. Norharman also inhibits chaperon GRP 
78 function by binding to it and reduces cellular energy 
stores by inhibiting the enzyme triphosphate isomerase 
and altering the glycolysis pathway. Subsequently, these 
adverse effects can cause neural permanent damage. 
Therefore, this evidence could explain the increasing ef-
fects of norharman on the susceptibility of the CNS to 
seizures-inducing substances [16, 25]. Accordingly, an-
other mechanism proposed is the effects of norharman as 
a competitive inhibitor of the enzyme monoamine oxi-
dase, which increases the concentration of serotonin in 
tissues. Moreover, these alkaloids can bind to serotonin 
receptors, as a regulatory molecule that regulates the 
natural balance between excitatory and inhibitory neu-
rotransmission [26]. Monoamine-Oxidase (MAO) regu-
lates the levels of dopamine, serotonin, and noradrena-
line in nerve tissue. Besides, it is required for proper 
nerve growth due to the dual role of monoamines in neu-
rotransmission and morphogenesis. Studies reported that 
decreased MAO activity in rats before or during preg-
nancy leads to changes in fetal brainstem development 
and the response of offspring to auditory stimuli [27]. 
5. Conclusion
Overall, the present study data revealed that using 
norharman in the pregnancy period, possibly through 
molecular changes in the level of neurons, like inhibi-
tory neurons damaging, promotes an imbalance between 
inhibitory and stimulatory factors in the brain. Further-
more, it predisposes to increased seizures in animals 
when seizure chemicals are received. Prenatal norharman 
consumption may generate the same effect in humans, 
which requires further studies. However, explaining the 
underlying mechanisms of such long-term effects in off-
spring is difficult and involves numerous genetic, epigen-
etic, growth, and environmental factors. According to the 
obtained results, it may be advisable for pregnant moth-
ers to limit the consumption of substances containing 
large amounts of beta-carboline during pregnancy.
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